Chunxiao Liu
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].
Journal: European journal of medicinal chemistry
Published: July 03, 2026
Discovery of Benfotiamine as a subnanomolar P2Y14R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation.
Journal: European journal of medicinal chemistry
Published: May 14, 2026
Discovery of Novel P2Y14R Inhibitors for Ameliorating Liver Fibrosis by Suppressing Hepatic Stellate Cell Activation.
Journal: Journal of medicinal chemistry
Published: November 03, 2025
Computational discovery and repurposing of chloramphenicol succinate as a potent P2Y14 receptor antagonist for inflammatory bowel disease therapy.
Journal: Journal of advanced research
Published: April 20, 2025
Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis.
Journal: European heart journal
Published: February 24, 2025
Research advances in the treatment of arthritis from natural products (2014-present).
Journal: Chinese journal of natural medicines
Published: August 13, 2024
Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors.
Journal: Pharmacology & therapeutics
Published: August 13, 2024
P2Y14R activation facilitates liver regeneration via CREB/DNMT3b/Dact-2/β-Catenin signals in acute liver failure.
Journal: Acta pharmaceutica Sinica. B
Published: June 25, 2024
Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment.
Journal: Journal of medicinal chemistry
Published: April 02, 2024
Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses.
Journal: Acta pharmaceutica Sinica. B
Published: March 01, 2024
Targeting P2Y14R protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis.
Journal: Nature communications
Published: January 07, 2023
GPR105-Targeted Therapy Promotes Gout Resolution as a Switch Between NETosis and Apoptosis of Neutrophils.
Journal: Frontiers in immunology
Published: February 06, 2022
Last Updated: 09/26/2026